Traina Shana B, Slee April, Woo Sangsoon, Canovatchel William
Janssen Global Services, LLC, Raritan, NJ, USA.
Axio Research, Seattle, WA, USA.
Diabetes Ther. 2015 Dec;6(4):611-625. doi: 10.1007/s13300-015-0145-8. Epub 2015 Nov 25.
The aim of this study was to examine the influence of weight change experiences over time on motivation to perform diabetes self-care behaviors using data from a study of canagliflozin (an agent that inhibits sodium glucose co-transporter 2) versus glimepiride in dual therapy with metformin and background diet/exercise.
Weight and motivation for performing healthy behaviors were collected at baseline and over time. The motivation questionnaire enabled categorization into two groups: those performing or not performing health behaviors. Four distinct patterns of weight change were determined: losing weight, gaining weight, and two patterns for fluctuating weight. The relationships between these patterns and motivation for weight loss, following a diet, and exercise were examined using logistic regression models.
Of 1182 subjects, more than half were already performing behaviors to lose weight, diet, and exercise at baseline. Among those who were not, 52% (246/474) started taking action to lose weight after baseline, 54% (241/448) started following a diet, and 42% (232/556) started exercising. Weight change patterns were significantly related to performance of healthy behaviors at follow-up (week 36). Compared to the weight gain pattern, those who experienced a continuous weight loss pattern from baseline to week 36 were 2.2 (95% confidence interval 1.49, 3.37) times more likely to perform the healthy behaviors. Baseline behavior and confidence were also predictive of performing healthy behaviors.
The current work highlights the importance of weight change patterns for performance of diabetes self-care. Tracking weight patterns over time, assessing confidence for performance of healthy behaviors, and being aware of the relationship between weight changes and diabetes self-care behaviors are viable, concrete ways to practice patient-centered care.
Janssen Global Services, LLC.
本研究旨在利用一项关于卡格列净(一种抑制钠-葡萄糖协同转运蛋白2的药物)与格列美脲联合二甲双胍及基础饮食/运动治疗的研究数据,探讨体重随时间变化的经历对糖尿病自我护理行为动机的影响。
在基线期及随访期间收集体重和健康行为动机数据。动机问卷可将受试者分为两组:进行或未进行健康行为的组。确定了四种不同的体重变化模式:体重减轻、体重增加以及两种体重波动模式。使用逻辑回归模型研究这些模式与减肥、饮食和运动动机之间的关系。
在1182名受试者中,超过一半在基线期就已经在进行减肥、饮食和运动行为。在未进行这些行为的受试者中,52%(246/474)在基线期后开始采取减肥行动,54%(241/448)开始控制饮食,42%(232/556)开始运动。体重变化模式与随访期(第36周)的健康行为表现显著相关。与体重增加模式相比,从基线期到第36周经历持续体重减轻模式的受试者进行健康行为的可能性高2.2倍(95%置信区间1.49,3.37)。基线行为和信心也是健康行为表现的预测因素。
当前研究突出了体重变化模式对糖尿病自我护理的重要性。随时间追踪体重模式、评估健康行为表现的信心以及了解体重变化与糖尿病自我护理行为之间的关系,是实施以患者为中心护理的可行且具体的方法。
杨森全球服务有限责任公司